From: The role of the intra-abdominal view in complicated intra-abdominal infections
Preoperative | n (%) (total n = 283) |
Sex, male | 132 (47) |
Age, years | 64 (49–74)a |
BMI | 21 (19–24)a |
Charlson Comorbidity Index | 1 (0–5)a |
Immunosuppression | 54 (19) |
Malignant diseases | |
Local solid malignant tumor | 35 (12) |
Solid metastatic tumor or lymphoma | 45 (16) |
Sepsis classification | |
No sepsis | 204 (72) |
Sepsis | 60 (21) |
Septic shock | 19 (7) |
Hospital-acquired cIAI | 62 (22) |
Intraoperative | n (%) |
Delay from symptoms to operation < 24 h | 79 (28) |
Perforated organ | |
Gastroduodenal | 32 (11) |
Small bowel | 30 (11) |
Colorectal | 101 (36) |
Appendix | 109 (39) |
Gallbladder | 11 (4) |
Operation | |
Laparotomy | 152 (54) |
Laparoscopy | 110 (39) |
Converted from laparoscopy to laparotomy | 21 (7) |
Open abdomen | 5 (2) |
Postoperative peritonitis | 38 (13) |
Mannheim Peritonitis Index | 26 (22–32)a |
WSES Sepsis Severity Score | 6 (3–9)a |
APACHE-II | 9 (6–15)a |
Postoperative | n (%) |
CRP, highest value, mg/l | 304 (244–364)a |
Reoperations | 36 (13) |
Postoperative abscess | 28 (10) |
Clavien-Dindo classification, in-hospital | |
0 | 111 (39) |
1 | 47 (17) |
2 | 38 (13) |
3a | 28 (10) |
3b | 25 (9) |
4a | 7 (2) |
4b | 3 (1) |
5 | 24 (8) |
Length of hospital stay, days | 6 (3–11)a |
ICU admission | 57 (20) |
Renal replacement therapy | 2 (1) |
Peak SOFA score at ICU | 8 (6–10)a |
Prolonged (> 12 h) recovery room stay | 25 (9) |
Mortality, 30 days | 29 (10) |
SCIAS or 30-day mortality | 71 (25) |
Mortality, 90 days | 37 (13) |